Cargando…

Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis

Autoantibodies against the complement component C1q (anti-C1q) are among the main biomarkers in lupus nephritis (LN) known to contribute to renal injury. C1q, the recognition subcomponent of the complement classical pathway, forms a heterotetrameric complex with C1r and C1s, and can also associate a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radanova, Maria, Vasilev, Vasil, Mihaylova, Galya, Kosturkova, Mariya, Kishore, Uday, Roumenina, Lubka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409282/ https://www.ncbi.nlm.nih.gov/pubmed/36012546 http://dx.doi.org/10.3390/ijms23169281

Ejemplares similares

Long Non-Coding RNAs as New Biomarkers in Lupus Nephritis: A Connection Between Present and Future
por: Mihaylova, Galya, et al.
Publicado: (2020)

Autoantibodies Against C3b—Functional Consequences and Disease Relevance
por: Vasilev, Vasil V., et al.
Publicado: (2019)

Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs
por: Hurler, Lisa, et al.
Publicado: (2022)

C3‐dependent effector functions of complement
por: Zarantonello, Alessandra, et al.
Publicado: (2022)

SERPING1 Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE
por: Drouet, Christian, et al.
Publicado: (2022)

Editorial: State-of-the-Art Research on C1q and the Classical Complement Pathway
por: Kishore, Uday, et al.
Publicado: (2016)

C1-esterase inhibitor (C1INH) implication in systemic inflammation in sepsis
por: Igonin, A, et al.
Publicado: (2010)

C1 Complex: An Adaptable Proteolytic Module for Complement and Non-Complement Functions
por: Lu, Jinhua, et al.
Publicado: (2017)

Combined anti-C1-INH and radiotherapy against glioblastoma
por: Liljedahl, Emma, et al.
Publicado: (2023)

Hereditary angioedema with C1 inhibitor (C1-INH) deficit: the strength of recognition (51 cases)
por: Fragnan, N.T.M.L., et al.
Publicado: (2018)

Clinical and genetic features of hereditary angioedema with and without C1‐inhibitor (C1‐INH) deficiency in Japan
por: Hashimura, Chinami, et al.
Publicado: (2021)

Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)
por: Parsopoulou, Faidra, et al.
Publicado: (2022)

Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE
por: Andarawewa, Shimalee, et al.
Publicado: (2021)

Emerging and Novel Functions of Complement Protein C1q
por: Kouser, Lubna, et al.
Publicado: (2015)

Physicochemical and Biological Characterization of rhC1INH Expressed in CHO Cells
por: Zubareva, Ekaterina, et al.
Publicado: (2021)

A Case of Acquired Angioedema with Low C1 Inhibitor (C1-INH) Associated with Splenic Marginal Zone Lymphoma
por: Abdel-Samad, Nizar N., et al.
Publicado: (2019)

Prognostic Implications of the Complement Protein C1q in Gliomas
por: Mangogna, Alessandro, et al.
Publicado: (2019)

C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway
por: Wu, Wen-Jun, et al.
Publicado: (2020)

Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE)
por: Palao-Ocharan, Paola, et al.
Publicado: (2022)

Autoantibodies against complement component C1q in systemic lupus erythematosus
por: Trendelenburg, Marten
Publicado: (2021)

Effectiveness of C1-INH therapy in angiotensin converting enzyme inhibitor induced angioedema
por: Kovaltchouk, Uliana, et al.
Publicado: (2021)

A patient with hereditary angioedema (HAE) with normal C1-INH and SLE with pregnancy
por: Taha, Omar S., et al.
Publicado: (2022)

Complement’s C1 Complex, Factor H and the X Factor: A Personal Tribute to Prof. Robert B. Sim
por: Kishore, Uday
Publicado: (2021)

Diagnostic performance of serum cystatin C and complement component 1q in lupus nephritis
por: Xu, Bei, et al.
Publicado: (2019)

Case report: lupus nephritis with autoantibodies to complement alternative pathway proteins and C3 gene mutation
por: Nozal, Pilar, et al.
Publicado: (2015)

Structure of the C1r–C1s interaction of the C1 complex of complement activation
por: Almitairi, Jamal O. M., et al.
Publicado: (2018)

A Compound Mutation (c.953C<G and c.49G<A) Aggravates Functional Impairments of C1-INH in Hep G2 Cells
por: Xu, Ying-Yang, et al.
Publicado: (2018)

A longitudinal study of C1q and anti-C1q autoantibodies in homologous and heterologous pregnancies for predicting pre-eclampsia
por: Agostinis, Chiara, et al.
Publicado: (2022)

Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age
por: Hsu, Florence Ida, et al.
Publicado: (2022)

A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the Staphylococcus aureus SSL7 Protein
por: Yatime, Laure, et al.
Publicado: (2018)

Complement C3 is a novel modulator of the anti-factor VIII immune response
por: Rayes, Julie, et al.
Publicado: (2018)

The expression of C1 inhibitor (C1INH) in macrophages is upregulated by retinal pigment epithelial cells – implication in subretinal immune privilege in the aging eye
por: Luo, Chang, et al.
Publicado: (2018)

Molecular signatures of intrarenal complement receptors C3AR1 and C5AR1 correlate with renal outcome in human lupus nephritis
por: Tampe, Désirée, et al.
Publicado: (2022)

Complement Component 5 (C5) Deficiency Improves Cognitive Outcome After Traumatic Brain Injury and Enhances Treatment Effects of Complement Inhibitors C1-Inh and CR2-Crry in a Mouse Model
por: Chen, Min, et al.
Publicado: (2023)

Trichinella spiralis Paramyosin Binds Human Complement C1q and Inhibits Classical Complement Activation
por: Sun, Ran, et al.
Publicado: (2015)

Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert(®) (C1-INH) Registry
por: Bygum, Anette, et al.
Publicado: (2016)

Oversulfated Chondroitin Sulfate Inhibits the Complement Classical Pathway by Potentiating C1 Inhibitor
por: Zhou, Zhao-Hua, et al.
Publicado: (2012)

Correction: Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age
por: Hsu, Florence Ida, et al.
Publicado: (2022)

Involvement of enhanced expression of classical complement C1q in atherosclerosis progression and plaque instability: C1q as an indicator of clinical outcome
por: Sasaki, Shoh, et al.
Publicado: (2022)

C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases
por: Zhao, Fei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s0u2ibqtbbmo9er66ccr8i6gei